Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243580 · ClinicalTrials.gov registry record · Phase 1
AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol
A Phase 1 study, sponsored by Agile Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01243580 is a Phase 1 study that has completed, run by Agile Therapeutics. The registered enrollment target is 36 participants.
The verdict
NCT01243580, a Phase 1 study, has completed, sponsored by Agile Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
Pharmacokinetics and safety of AG200-15 over two consecutive cycles of therapy will be evaluated.
Interventions
- DRUG AG200-15
- DRUG Ortho-Cyclen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01243580
The ClinicalTrials.gov registry entry for NCT01243580 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agile Therapeutics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AG200-15 is the first listed.
NCT01243580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01243580 about?
NCT01243580 is a clinical study titled "AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol". Pharmacokinetics and safety of AG200-15 over two consecutive cycles of therapy will be evaluated.
What is the current status of trial NCT01243580?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2009-08. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01243580?
The interventions under investigation include: AG200-15 (DRUG), Ortho-Cyclen (DRUG).
Who is sponsoring clinical trial NCT01243580?
This trial is sponsored by Agile Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.